Induced pluripotent stem cells for regenerative medicine

Annual Review of Biomedical Engineering

Volumn 16, Issue , 2014, Pages 277-294

  Hirschi, Karen K ^a   Li, Song ^b   Roy, Krishnendu ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of California at Berkeley   (United States)

^c Wallace H Coulter Department of Biomedical Engineering   (United States)

Author keywords

cell engineering; directed differentiation; iPS cells; tissue regeneration

Indexed keywords

CELL ENGINEERING; CYTOLOGY; STEM CELLS; TISSUE REGENERATION;

BIOCHEMICAL TECHNIQUES; CELL REPROGRAMMING; DIRECTED DIFFERENTIATIONS; DRUG SCREENING; INDUCED PLURIPOTENT STEM CELLS; IPS CELLS; REGENERATIVE MEDICINE; SOMATIC CELLS;

MOLECULAR BIOLOGY;

BIOENGINEERING; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL MANIPULATION; HIGH THROUGHPUT SCREENING; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; REVIEW; TISSUE DIFFERENTIATION; ANIMAL; BIOMEDICAL ENGINEERING; BIOREACTOR; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG DEVELOPMENT; HUMAN; INDUCED PLURIPOTENT STEM CELL; LIVER CELL; METABOLISM; MOUSE; NERVE CELL; PHENOTYPE; PRECLINICAL STUDY; PROCEDURES; REGENERATION; SIGNAL TRANSDUCTION;

BIOMATERIAL;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOMEDICAL ENGINEERING; BIOREACTORS; CELL DIFFERENTIATION; CELL LINEAGE; CELL SURVIVAL; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; HEPATOCYTES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; NEURONS; PHENOTYPE; REGENERATION; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION;

EID: 84904293670     PISSN: 15239829     EISSN: 15454274     Source Type: Book Series    
DOI: 10.1146/annurev-bioeng-071813-105108     Document Type: Review

References (111)

1. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-76
2. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-20
3. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-72
4. Chin MH, Mason MJ, Xie W, Volinia S, Singer M, et al. 2009. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5:111-23
5. Feng Q, Lu SJ, Klimanskaya I, Gomes I, Kim D, et al. 2010. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28:704-12
6. Narsinh KH, Sun N, Sanchez-Freire V, Lee AS, Almeida P, et al. 2011. Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. J. Clin. Investig. 121:1217-21
7. Bilic J, Izpisua Belmonte JC. 2012. Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart? Stem Cells 30:33-41
8. Abyzov A, Mariani J, Palejev D, Zhang Y, Haney MS, et al. 2012. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 492:438-42
9. Yamanaka S. 2012. Induced pluripotent stem cells: past, present and future. Cell Stem Cell 10:678-84
10. Okita K, Ichisaka T, Yamanaka S. 2007. Generation of germline-competent induced pluripotent stem cells. Nature 448:313-17
11. Zhao T, Zhang ZN, Rong Z, Xu Y. 2011. Immunogenicity of induced pluripotent stem cells. Nature 474:212-15
12. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. 2008. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949-53
13. Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, et al. 2011. A more eficient method to generate integration-free human iPS cells. Nat. Methods 8:409-12
14. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, et al. 2010. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7:618-30
15. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, et al. 2009. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4:472-76
16. Judson RL, Babiarz JE, Venere M, Blelloch R. 2009. Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat. Biotechnol. 27:459-61
17. Melton C, Judson RL, Blelloch R. 2010. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 463:621-26
18. Anokye-Danso F, Trivedi CM, Juhr D, Gupta M, Cui Z, et al. 2011. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8:376-88
19. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, et al. 2008. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 26:795-97
20. Li Y, Zhang Q, Yin X, Yang W, Du Y, et al. 2011. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res. 21:196-204
21. Li W, Tian E, Chen ZX, Sun G, Ye P, et al. 2012. Identification of Oct4-activating compounds that enhance reprogramming efficiency. Proc. Natl. Acad. Sci. USA 109:20853-58
22. Ichida JK, Blanchard J, Lam K, Son EY, Chung JE, et al. 2009. A small-molecule inhibitor of Tgf-β signaling replaces Sox2 in reprogramming by inducing Nanog. Cell Stem Cell 5:491-503
23. Lin T, Ambasudhan R, Yuan X, Li W, Hilcove S, et al. 2009. A chemical platform for improved induction of human iPSCs. Nat. Methods 6:805-8
24. Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR, Ding S. 2008. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3:568-74
25. Buganim Y, Faddah DA, Jaenisch R. 2013. Mechanisms and models of somatic cell reprogramming. Nat. Rev. Genet. 14:427-39
26. Hou P, Li Y, Zhang X, Liu C, Guan J, et al. 2013. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341:651-54
27. Downing TL, Soto J, Morez C, Houssin T, Fritz A, et al. 2013. Biophysical regulation of epigenetic state and cell reprogramming. Nat. Mater. 12:1154-62
28. Fluri DA, Tonge PD, Song H, Baptista RP, Shakiba N, et al. 2012. Derivation, expansion and differentiation of induced pluripotent stem cells in continuous suspension cultures. Nat. Methods 9:509-16
29. Zhao Y, Yin X, Qin H, Zhu F, Liu H, et al. 2008. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 3(5):475-79
30. Singh A, Suri S, Lee T, Chilton JM, Cooke MT, et al. 2013. Adhesion strength-based, label-free isolation of human pluripotent stem cells. Nat. Methods 10(5):438-44
31. Rais Y, Zviran A, Geula S, Gafni O, Chomsky E, et al. 2013. Deterministic direct reprogramming of somatic cells to pluripotency. Nature 502:65-70
32. Lei Y, Schaffer DV. 2013. A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation. Proc. Natl. Acad. Sci. USA 110(52):5039-48
33. Serra M, Brito C, Correia C, Alves PM. 2012. Process engineering of human pluripotent stem cells for clinical application. Trends Biotechnol. 30(6):350-59
34. Wilson JL, McDevitt TC. 2013. Stem cell microencapsulation for phenotypic control, bioprocessing, and transplantation. Biotechnol. Bioeng. 110(3):667-82
35. Villa-Diaz LG, Ross AM, Lahann J, Krebsbach PH. 2013. Concise review: The evolution of human pluripotent stem cell culture: from feeder cells to synthetic coatings. Stem Cells 31(1):1-7
36. de Peppo GM, Sladkova M, Sjövall P, Palmquist A, Oudina K, et al. 2013. Human embryonic stem cell-derived mesodermal progenitors display substantially increased tissue formation compared to human mesenchymal stem cells under dynamic culture conditions in a packed bed/column bioreactor. Tissue Eng. Part A 19(1-2):175-87
37. Serra M, Brito C, Correia C, Alves PM. 2012. Process engineering of human pluripotent stem cells for clinical application. Trends Biotechnol. 30(6):350-59
38. Nakagawa Y, Nakamura S, Nakajima M, Endo H, Dohda T, et al. 2013. Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes. Exp. Hematol. 41(8):742-48
39. Cimetta E, Sirabella D, Yeager K, Davidson K, Simon J, et al. 2013. Microfluidic bioreactor for dynamic regulation of early mesodermal commitment in human pluripotent stem cells. Lab. Chip 13(3):355-64
40. Shafa M, Day B, Yamashita A, Meng G, Liu S, et al. 2012. Derivation of iPSCs in stirred suspension bioreactors. Nat. Methods 9(5):465-66
41. Kinney MA, Sargent CY, McDevitt TC. 2011. The multiparametric effects of hydrodynamic environments on stem cell culture. Tissue Eng. Part B Rev. 17(4):249-62
42. Fridley KM, Fernandez I, Li MT, Kettlewell RB, Roy K. 2010. Unique differentiation profile of mouse embryonic stem cells in rotary and stirred tank bioreactors. Tissue Eng. Part A 16(11):3285-98
43. de Peppo GM, Marcos-Campos I, Kahler DJ, Alsalman D, Shang L, et al. 2013. Engineering bone tissue substitutes from human induced pluripotent stem cells. Proc. Natl. Acad. Sci. USA 110(21):8680-85
44. Lu L, Mende M, Yang X, Körber HF, Schnittler HJ, et al. 2012. Design and validation of a bioreactor for simulating the cardiac niche: a system incorporating cyclic stretch, electrical stimulation, and constant perfusion. Tissue Eng. Part A 19(3-4):403-14
45. Liao J, Guo X, Grande-Allen KJ, Kasper FK, Mikos AG. 2010. Bioactive polymer/extracellular matrix scaffolds fabricated with a flow perfusion bioreactor for cartilage tissue engineering. Biomaterials 31(34):8911-20
46. Want AJ, Nienow AW, Hewitt CJ, Coopman K. 2012. Large-scale expansion and exploitation of pluripo-tent stem cells for regenerative medicine purposes: beyond the T flask. Regen. Med. 7(1):71-84
47. Sun LY, Lin SZ, Li YS, Harn HJ, Chiou TW. 2011. Functional cells cultured on microcarriers for use in regenerative medicine research. Cell Transplant. 20(1):49-62
48. Olmer R, Haase A, Merkert S, Cui W, Palecek J, et al. 2010. Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res. 5(1):51-64
49. Cao N, Liang H, Huang J, Wang J, Chen Y, et al. 2013. Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions. Cell Res. 23(9):1119-32
50. Wang Y, Chou BK, Dowey S, He C, Gerecht S, Cheng L. 2013. Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions. Stem Cell Res. 11(3):1103-16
51. TM Medium conditions. Methods Mol. Biol. 997:57-72
52. Yang JJ, Liu JF, Kurokawa T, Kitada K, Gong JP. 2012. Hydrogels as feeder-free scaffolds for longterm self-renewal of mouse induced pluripotent stem cells. J. Tissue Eng. Regen. Med. In press. doi: 10.1002/term.1640
53. Kehoe DE, Jing D, Lock LT, Tzanakakis ES. 2010. Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng. Part A 16(2):405-21
54. Mauritz C, Schwanke K, Reppel M, Neef S, Katsirntaki K, et al. 2008. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118:507-17
55. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, et al. 2009. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104:e30-41
56. Zwi L, Caspi O, Arbel G, Huber I, Gepstein A, et al. 2009. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120:1513-23
57. Shimoji K, Yuasa S, Onizuka T, Hattori F, Tanaka T, et al. 2010. G-CSF promotes the proliferation of developing cardiomyocytes in vivo and in derivation from ESCs and iPSCs. Cell Stem Cell 6:227-37
58. Engler AJ, Carag-Krieger C, Johnson CP, Raab M, Tang HY, et al. 2008. Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: Scar-like rigidity inhibits beating. J. Cell Sci. 121:3794-802
59. Nunes SS, Miklas JW, Liu J, Aschar-Sobbi R, Xiao Y, et al. 2013. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat. Methods 10:781-87
60. + embryonic-stem-cell-derived population. Nature 453:524-28
61. Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, et al. 2008. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118:498-506
62. Taura D, Sone M, Homma K, Oyamada N, Takahashi K, et al. 2009. Induction and isolation of vascular cells from human induced pluripotent stem cells-brief report. Arterioscler. Thromb. Vasc. Biol. 29:1100-3
63. + cardiovascular progenitors. FASEB J. 24:700-11
64. + progenitor cells by combined modulation of the MEK/ERK and BMP4 signaling pathways. Blood 116:5762-72
65. Choi KD, Yu J, Smuga-Otto K, Salvagiotto G, Rehrauer W, et al. 2009. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27:559-67
66. Grigoriadis AE, Kennedy M, Bozec A, Brunton F, Stenbeck G, et al. 2010. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood 115:2769-76
67. Hu BY, Zhang SC. 2009. Differentiation of spinal motor neurons from pluripotent human stem cells. Nat. Protoc. 4:1295-304
68. Hu BY, Du ZW, Zhang SC. 2009. Differentiation of human oligodendrocytes from pluripotent stem cells. Nat. Protoc. 4:1614-22
69. Lee G, Chambers SM, Tomishima MJ, Studer L. 2010. Derivation of neural crest cells from human pluripotent stem cells. Nat. Protoc. 5:688-701
70. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. 2009. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27:275-80
71. Zhou J, Su P, Li D, Tsang S, Duan E, Wang F. 2010. High-efficiency induction of neural conversion in human ESCs and human induced pluripotent stem cells with a single chemical inhibitor of transforming growth factor beta superfamily receptors. Stem Cells 28:1741-50
72. Haque A, Yue XS, Motazedian A, Tagawa Y, Akaike T. 2012. Characterization and neural differentiation of mouse embryonic and induced pluripotent stem cells on cadherin-based substrata. Biomaterials 33:5094-106
73. Kuo YC, Huang MJ. 2012. Material-driven differentiation of induced pluripotent stem cells in neuron growth factor-grafted poly(epsilon- caprolactone)-poly(beta-hydroxybutyrate) scaffolds. Biomaterials 33:5672-82
74. Keung AJ, Asuri P, Kumar S, Schaffer DV. 2012. Soft microenvironments promote the early neurogenic differentiation but not self-renewal of human pluripotent stem cells. Integr. Biol. (Camb.) 4:1049-58
75. Saha K, Keung AJ, Irwin EF, Li Y, Little L, et al. 2008. Substrate modulus directs neural stem cell behavior. Biophys. J. 95:4426-38
76. Ankam S, Suryana M, Chan LY, Moe AA, Teo BK, et al. 2013. Substrate topography and size determine the fate of human embryonic stem cells to neuronal or glial lineage. Acta Biomater. 9:4535-45
77. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, et al. 2008. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA 105:5856-61
78. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, et al. 2009. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136:964-77
79. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, et al. 2008. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321:1218-21
80. Karumbayaram S, Novitch BG, Patterson M, Umbach JA, Richter L, et al. 2009. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 27:806-11
81. Marchetto MC, Carromeu C, Acab A, Yu D, Yeo GW, et al. 2010. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143:527-39
82. Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, et al. 2011. Modelling schizophrenia using human induced pluripotent stem cells. Nature 473:221-25
83. Lee G, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, et al. 2009. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461:402-6
84. Wang A, Tang Z, Park IH, Zhu Y, Patel S, et al. 2011. Induced pluripotent stem cells for neural tissue engineering. Biomaterials 32:5023-32
85. Tsuji O, Miura K, Okada Y, Fujiyoshi K, Mukaino M, et al. 2010. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc. Natl. Acad. Sci. USA 107:12704-9
86. Si-Tayeb K, Noto FK, Sepac A, Sedlic F, Bosnjak ZJ, et al. 2010. Generation of human induced pluripo-tent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Dev. Biol. 10:81
87. Sullivan GJ, Hay DC, Park IH, Fletcher J, Hannoun Z, et al. 2010. Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology 51:329-35
88. Chen YF, Tseng CY, Wang HW, Kuo HC, Yang VW, Lee OK. 2012. Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol. Hepatology 55:1193-203
89. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. 2008. In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature 455:627-32
90. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, et al. 2010. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142:375-86
91. Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, et al. 2012. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485:593-98
92. Song K, Nam YJ, Luo X, Qi X, Tan W, et al. 2012. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 485:599-604
93. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Südhof TC, Wernig M. 2010. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463:1035-41
94. Ambasudhan R, Talantova M, Coleman R, Yuan X, Zhu S, et al. 2011. Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions. Cell Stem Cell 9:113-18
95. Karow M, Sanchez R, Schichor C, Masserdotti G, Ortega F, et al. 2012. Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells. Cell Stem Cell 11:471-76
96. Huang P, He Z, Ji S, Sun H, Xiang D, et al. 2011. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 475:386-89
97. Sekiya S, Suzuki A. 2011. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 475:390-93
98. Efe JA, Hilcove S, Kim J, Zhou H, Ouyang K, et al. 2011. Conversion of mouse fibroblasts into cardio-myocytes using a direct reprogramming strategy. Nat. Cell Biol. 13:215-22
99. Thier M, Worsdorfer P, Lakes YB, Gorris R, Herms S, et al. 2012. Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell 10:473-79
100. Margariti A, Winkler B, Karamariti E, Zampetaki A, Tsai TN, et al. 2012. Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. Proc. Natl. Acad. Sci. USA 109:13793-98
101. Karamariti E, Margariti A, Winkler B, Wang X, Hong X, et al. 2013. Smooth muscle cells differentiated from reprogrammed embryonic lung fibroblasts through DKK3 signaling are potent for tissue engineering of vascular grafts. Circ. Res. 112:1433-43
102. Nunes SS, Song H, Chiang CK, Radisic M. 2011. Stem cell-based cardiac tissue engineering. J. Cardio-vasc. Transl. Res. 4(5):592-602
103. Aguado BA, Mulyasasmita W, Su J, Lampe KJ, Heilshorn SC. 2012. Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers. Tissue Eng. Part A 18(7-8):806-15
104. Bellin M, Marchetto MC, Gage FH, Mummery CL. 2012. Induced pluripotent stem cells: the new patient? Nat. Rev. Mol. Cell Biol. 13(11):713-26
105. Malan D, Friedrichs S, Fleischmann BK, Sasse P. 2011. Cardiomyocytes obtained from induced pluripo-tent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro. Circ. Res. 109(8):841-47
106. Sinnecker D, Goedel A, Dorn T, Dirschinger RJ, Moretti A, Laugwitz KL. 2013. Modeling long-QT syndromes with iPS cells. J. Cardiovasc. Transl. Res. 6(1):31-36
107. Song B, Sun G, Herszfeld D, Sylvain A, Campanale NV, et al. 2012. Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis. Stem Cell Res. 8(2):259-73
108. Yahata N, Asai M, Kitaoka S, Takahashi K, Asaka I, et al. 2011. Anti-Aβdrug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease. PLoS ONE 6(9):e25788
109. Tanaka T, Takahashi K, Yamane M, Tomida S, Nakamura S, et al. 2012. Induced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery. Blood 120(6):1299-308
110. Zou J, Mali P, Huang X, Dowey SN, Cheng L. 2011. Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. Blood 118(17):4599-608
111. Liu J, Verma PJ, Evans-Galea MV, Delatycki MB, Michalska A, et al. 2011. Generation of induced pluripotent stem cell lines from Friedreich ataxia patients. Stem Cell Rev. 7(3):703-13